Co-Founder & Head of Medical Affairs PetDx San Diego, California, United States
Major veterinary medical organization agree that the early identification of cancer is important: however, current screening paradigms (annual/semi-annual physical exam and routine minimum database) are inadequate for early detection of most canine cancers. So, it's probably no surprise to hear that most dogs are diagnosed with cancer after the family notices clinical signs due to the disease. This session will review data from a cohort of over 350 cancer-diagnosed dogs, evaluating how the disease come to clinical attention. The session will then discuss a novel, blood-based approach to cancer screening - Liquid biopsy testing. The session will conclude by answering the question "when should I start screening a dog for cancer' by reviewing data from a large study of over 3,000 cancer-diagnosed dogs in which median age at cancer diagnosis was analyzed by breed and weight.
Learning Objectives:
Review the current state of cancer screening in dogs
Discuss how canine cancer currently comes to clinical attention for diagnosis
Evaluate the benefits and limitations of liquid biopsy testing as a novel screening tool for dogs
Consider the appropriate age to initiate cancer screening in individual dogs based on their breed or weight